Abbott signals recovery in device sales as hospital staff shortages ease
United States: Abbott Laboratories said on Wednesday most delayed non-urgent medical procedures had resumed globally three years into the COVID-19 pandemic as hospital staff shortages eased and customers became regular with check-ups, sending shares up 7%. The much-awaited recovery in elective surgeries led the company to effectively raise forecast for its core business, even as COVID […] More